Skip to main content
. 2021 Oct 11;2021:9996193. doi: 10.1155/2021/9996193

Figure 4.

Figure 4

Utilisation of insulin glargine 300 IU/ml (Gla-300) as a % of total insulin glargine (DDD based) across Europe over time